Comparison of Intravenous Brivaracetam Versus Levetiracetam in the Management of Status Epilepticus
Status:
COMPLETED
Trial end date:
2025-08-16
Target enrollment:
Participant gender:
Summary
Brivaracetam is increasingly being studied in adult status epilepticus populations, evidence in pediatric patients remains sparse, with only limited case series and observational studies reporting favorable outcomes. This study aims at direct comparison between intravenous brivaracetam and levetiracetam in the acute management of pediatric status epilepticus.